Bristol-Myers Squibb
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Bristol Myers Squibb (BMS) is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. BMS embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of Bristol-Myers Squibb
Chris Boerner, Ph.D.
Summary:
Headquartered in New York, New York, Bristol-Myers Squibb is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Chris Boerner, Ph.D. and Giovanni Caforio, MD serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $180,751 to Republican causes and $173,336 to Democratic causes. Under their tenure, Bristol-Myers Squibb currently holds a 'High Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$180,751
$173,336
Republican
Democrat
Shareholder Proposals
Expand Summary
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 5/7/24 | Governance | John Chevedden | Executives to Retain Significant Stock | Against | 38.53% |
| 5/7/24 | Governance | Kenneth Steiner | Independent Board Chairman | Against | 31.71% |
| 5/2/23 | Governance | Kenneth Steiner | Require the Chairman of the Board to be an Independent Director | Against | 31.80% |
| 5/2/23 | Governance | John Chevedden | Reduce the Number of Shares Required to Call a Special Meeting | Against | 5.90% |
| 5/2/23 | Social | National Center for Public Policy Research | Commission an Audit Analyzing the Impacts of Diversity, Equity, and Inclusion Policies | Against | 1.60% |
| 5/3/22 | Governance | Mercy Investment Services | Independent Board Chair | Against | 44.58% |
| 5/3/22 | Governance | Kenneth Steiner | Special Meetings - Reduce Ownership Req. to 10% | Against | 34.33% |